Quantum Clinical Trials is categorized under Clinics in Washington, DC and active since 1995.
Quantum Clinical Trials was established in 1995, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Raj Malik at the company’s single location by writing to 3801 Connecticut Avenue Nw # 100b, Washington, District of Columbia DC 20008 or by phoning (202) 364-7071. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Quantum Clinical Trials |
| Contact Person: | Raj Malik |
| Address: | 3801 Connecticut Avenue Nw # 100b, Washington, District of Columbia 20008 |
| Phone Number: | (202) 364-7071 |
| Website Address: | qct-inc-usa.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Quantum Clinical Trials was started in 1995 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Raj Malik for inquiries that concern Quantum Clinical Trials by calling the company number (202) 364-7071, as your correspondence is most welcome. Additionally, the physical location of the single location of Quantum Clinical Trials can be found at the coordinates 38.938879,-77.060357 as well as the street address 3801 Connecticut Avenue Nw # 100b in Washington, District of Columbia 20008.
For its online presence, you may visit Quantum Clinical Trials’s website at qct-inc-usa.com and engage with its social media outlets through on Twitter and on Facebook.